As you know, Oppenheimer upgraded Relay Therapeutics Inc. ( RLAY ) to Outperform from Perform this week, and the stock saw a considerable boost. Since the upgrade on the 26th, shares are upI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges b ...